Prognostic Value off Bronchoalveolar Lavage Lymphocyte Count in Recently Diagnosed Pulmonary Sarcoidosis (7)
These two patients were, however, included in the treated group. The treated patients were older (mean, 41.1 years) than the nontreated patients (mean: 36.1 yr), but this difference was not statistically significant (p = 0.12). The two groups had similar lavage volume recovery (nontreated, 56.2 percent; treated, 60.5 percent [p = 0.15]; lavage total number of cells (18.8 X lOVml and 18.5 X lOVml [p = 0.94]; lavage lymphocyte percentages (27.8 percent and 35.3 percent [p = 0.09]), and lymphocyte counts (99 X lOVml [recovered lavage fluid] and 72xl03/ml, respectively [p = 0.15]). The other cell counts were also similar. buy cipro
The treated patients were equally distributed in the positive or negative (including those without biopsy) biopsy groups; however, the proportion of treated patients increased from lung roentgenogram stage 0 to 3 (p = 0.04) (Table 2). The proportion of treated patients was higher among the patients with a BAL lymphocyte count ^30 percent at diagnosis compared to those with lower lavage lymphocyte percent (31.9 percent and 17.7 percent, respectively). However, this difference did not reach statistical significance (p = 0.10). Most of the treated patients (18 of 24) required treatment at the first visit. From this subgroup, seven patients had a BAL lymphocyte count <30 percent and 11 had a count ^30 percent (61 percent).
Table 2—Proportion of Treated Patients According to Their Characteristics at the Time of Diagnosis
|Total No. of Subjects||Treated Subjects, % of Total||P|
|Chest x-ray stage|
|BAL lymphocyte count|